Search & Analyze

Alivus Life Sciences Ltd.

Healthcare

www.alivus.com BSE: 543322NSE: ALIVUS

₹1,101.101.60%

24 Jul, 4:01 PM

CMP₹1,101.10

Mkt Cap₹13.55K Cr

P/E24.01

P/B4.07

ROE18.94%

52W High₹1,193.30

52W Low₹830.00

Customise metrics bar

CMP

₹1,101.10

P/B Ratio

4.07

ROE

18.94%

ROCE

25.50%

Dividend Yield

0.45%

Sector

Healthcare

1Y Return

—

Period High

—

Period Low

—

Avg Volume

—

Price Performance

Close price (right axis)Volume (left axis)

Company Overview

Industry

Pharmaceuticals & Drugs

Sector

Healthcare

Founded

2011

Headquarters

Solapur, Maharashtra

Group

Glenmark

Chairman

Hiren K Patel

Managing Director

Yasir Rawjee

Company Secretary

Rudalf Corriea

Face Value

₹2

CIN

L74900PN2011PLC139963

Website

www.alivus.com

complianceofficer@alivus.com

Phone

02189 234456/234246

AI Insights· Alivus Life Sciences Ltd.

Ask AI Insights

Select a prompt below to get instant market analysis.

Suggested Prompts

🔒

AI Insights

Coming Soon

AI-powered company analysis is on its way.

Key Management

Rudalf Corriea

Company Secretary & Compliance Officer

Hiren K Patel

Chairman

Yasir Rawjee

Managing Director & Chief Executive Officer

Kaushikbhai N Patel

Non Executive Independent Director

Manju Agarwal

Non Executive Independent Director

TL Easwar

Non Executive Independent Director

Savan Godiawala

Non Executive Independent Director

Vinod Naik

Whole Time Director - Head of Technical Operations

ALIVUS

₹1,101.10

-1.6%